Targeted metastasis of cancer cells with elevated expression of CXCR4 to specific sites guided by the high level of SDF-1 suggests a new therapeutic strategy to interrupt the SDF-1/CXCR4 axis and inhibit cancer metastasis [4]. Here, CXCR4 is linked to cancer.